US10800774B2

Heterocyclic inhibitors of ATR kinase

University of Texas System

Abstract

The present invention relates to heterocyclic compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Maria Emilia Di Francesco
Priority date: August 17, 2017
Filing date: August 17, 2018
Grant date: October 13, 2020
Publication date: October 13, 2020
Language: en
PDF source: https://patentimages.storage.googleapis.com/0d/27/23/32022f1ba571b3/US10800774.pdf
Metadata fetched: August 29, 2026 00:26